Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Aflibercept 0.4 mg	75
Overall Study	STARTED	Laser Photocoagulation	38
Overall Study	SAF	Aflibercept 0.4 mg	75
Overall Study	SAF	Laser Photocoagulation	38
Overall Study	PKS	Aflibercept 0.4 mg	75
Overall Study	PKS	Laser Photocoagulation	0
Overall Study	AAS	Aflibercept 0.4 mg	75
Overall Study	AAS	Laser Photocoagulation	0
Overall Study	COMPLETED	Aflibercept 0.4 mg	68
Overall Study	COMPLETED	Laser Photocoagulation	36
Overall Study	NOT COMPLETED	Aflibercept 0.4 mg	7
Overall Study	NOT COMPLETED	Laser Photocoagulation	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04004208/flow